The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2026

Filed:

Dec. 22, 2020
Applicant:

Spinalcyte Llc, Houston, TX (US);

Inventors:

Pete O'heeron, Houston, TX (US);

Thomas Ichim, San Diego, CA (US);

Assignee:

SPINALCYTE LLC, Houston, TX (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/33 (2015.01); A61P 37/00 (2006.01); C12N 15/79 (2006.01);
U.S. Cl.
CPC ...
A61K 35/33 (2013.01); A61P 37/00 (2018.01); C12N 15/79 (2013.01);
Abstract

Disclosed are means of suppressing production of the inflammatory cytokine TNF-alpha through contact-dependent and contact-independent means by fibroblast populations and products and/or derivatives of fibroblast populations. In one embodiment, fibroblasts are cultured under conditions allowing proliferation of said fibroblasts, wherein said proliferative status of fibroblasts correlates with the ability to directly suppress TNF-alpha production, and/or to release one or more factors capable of suppressing TNF-alpha production. In one embodiment, fibroblasts are used for treatment of inflammatory diseases by their ability to suppress TNF-alpha production. In other embodiments, conditioned media and/or exosomes of said fibroblasts are utilized to treat inflammatory diseases by their ability to suppress TNF-alpha production.


Find Patent Forward Citations

Loading…